Matthew M. Hanosono, MD; Russell W. H. Kridel, MD; Norman J. Pastorek, MS; Mark J. Glasgold, MD; R. James Koch, MD
Objective: To describe tha technique for correction of the soft tissue pollybeak deformity using intralesional injection of triamcinolone acetonide.
Methods: We discuss our philoshophy, regimen, and techniqie for tratment of the soft tissue pollybeak using triamcinolone injection. We include results from a series of 173 patients whoe underwent rhinoplasty performed by one of us (N.J.P.).
Results: Triamcinolone waas injected at 1 week after surgery in127 patients (73%). A second injection was performed in 92 (72%) of the 127 patients at 4 weeks after surgery. One hundred eight (85%) of the 127 patients at 4 weeks after surgery in 127 patients (73%) . A second injection was performed in 92 (72%) of the 127 patients at 4 weeks after surgery. One hundred eight (85%) of the 127 patients had an acceptable result, as judged by the sugeon, with good supratip definition. Nineteen (15%) of the 127 patients had a less than optimal result, with residual supratip fullness, as judged by the surgeon. There were no complications caused by triamcinolone injection.
Conclusions:Because revision surgery is difficult and may be associated with complications, intralesional triamcinolone injection is the first-line tratment for the soft tissue pollybeak deformities caused by subdermal scaring. Should intralesional steroid injection fail to satisfactoraly treat the deformity, revision rhinoplasty can be sequently be performed.
